Zusammenfassung
Die pharmakodynamische Interaktion zwischen Lumefantrin und seinem Monodesbutyl-Analog (DBB) wurde bei 35 frischen Isolaten von Plasmodium falciparum untersucht. Beide Substanzen zeigten signifikante Wirkungskorrelation. Die geometrischen Mittelwerte für volle Hemmung der Schizontenreifung (GMCOC) lagen bei 536,8 nM für Lumefantrin, 246,0 nM für DBB, 235,5 nM für LUM-DBB 999:1, und 155,2 nM für LUM-DBB 995:5, mit signifikanten Unterschieden zwischen Lumefantrin und DBB sowie den LUM-DBB Kombinationen. Die Summen der fraktionellen Hemmwerte nach Berenbaum (SFIC) lagen für LUM-DBB 995:5 im Bereich von klarem Synergismus, wobei der Interaktionsgrad mit der effektiven Hemmkonzentration stieg.
Summary
The pharmacodynamic interaction between lumefantrine and its monodesbutyl analogue (DBB) has been investigated in 35 fresh isolates of Plasmodium falciparum. Both compounds showed highly significant activity correlation. The geometric mean values for complete inhibition of schizont maturation (GMCOC) were 536,8 nM for lumefantrine, 246.0 nM for DBB, 235,5 nM for LUM-DBB 999:1, and 155,2 nM for LUM-DBB 995:5, with significant activity differences between lumefantrine and DBB as well as the LUM-DBB combinations. For the combination of lumefantrine and DBB 995:5 the sums of the fractional inhibitory concentrations according to Berenbaum (SFIC) indicated marked synergism, the intensity of interaction rising with the effective inhibitory concentrations.
References
World Health Organization (1990) Practical chemotherapy of malaria. Report of a WHO Scientific Group. WHO Tech Rep Ser 805, WHO, Geneva, pp 124–126
Yeung S, Pongtavompinyo W, Hastings IM, Mills AJ, White NJ (2004) Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modelling to elucidating policy choices. Am J Trop Med Hyg 71 [Suppl 2]: 179–186
Noedl H, Allmendinger T, Prajakwong S, Wernsdorfer G, Wernsdorfer WH (2001) Desbutyl-benflumetol, a novel antimalarial compound: in vitro activity in fresh isolates of Plasmodium falciparum from Thailand. Antimicrob Agents Chemother 45: 2106–2109
Starzengruber P, Wernsdorfer G, Parizek M, Rojanawatsirivet C, Kollaritsch H, Wernsdorfer WH (2007) Specific pharmacokinetic interaction between lumefantrine and monodesbutyl-benflumetol in Plasmodium falciparum. Wien Klin Wochenschr 119 [Suppl 3]: 60–66
Pirker-Krassnig DK, Wernsdorfer G, Sirichaisinthop J, Rojanawatsirivet C, Kollaritsch H, Wernsdorfer WH (2004) Comparative study on the in vitro activity of lumefantrine and debutyl-benflumetol in fresh isolates of Plasmodium vivax from Thailand. Wien Klin Wochenschr 116 [Suppl 4]: 47–52
World Health Organization (1991) Basic malaria microscopy. Part I. WHO, Geneva, pp 67–68
Litchfield JT jr, Wilcoxon F (1949) A simplified method for evaluating dose-effect experiments. J Pharm Exp Ther 96: 99–113
Wernsdorfer WH, Wernsdorfer MG (1995) The evaluation of in vitro tests for the assessment of drug response in Plasmodium falciparum. Mitteilungen Oesterr Gesellsch Tropenmed Parasitol 17: 221–228
Berenbaum MC (1978) A method for testing for synergy with any number of agents. J Infect Dis 137: 122–130
Lefèvre G, Thomsen MS (1999) Clinical pharmacokinetics of artemether and lumefantrine (Riamet®). Clin Drug Invest 18: 467–480
Wernsdorfer WH (2004) Coartemether (artemether and lumefantrine): an oral antimalarial drug. Expert Rev Anti-infect Ther 2: 181–196
Traebert M, Dumotier B, Meister L, Hoffmann P, Dominguez-Estevez M, Suter M (2004) Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells. Eur J Pharmacol 484: 41–48
Wernsdorfer G, Wernsdorfer WH (2003) Malaria at the turn from the 2nd to the 3rd millennium. Wien Klin Wochenschr 115 [Suppl 3]: 2–9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Starzengruber, P., Kollaritsch, H., Sirichaisinthop, J. et al. Interaction between lumefantrine and monodesbutyl-benflumetol in Plasmodium falciparum in vitro. Wien Klin Wochenschr 120 (Suppl 4), 85–89 (2008). https://doi.org/10.1007/s00508-008-1080-8
Issue Date:
DOI: https://doi.org/10.1007/s00508-008-1080-8